Related Experiment Video
Updated: Jan 11, 2026
Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Early detection of urological tumors based on genomic characteristics of cell-free DNA fragments: a multi-center
Huiyong Zhang1,2, Caihong Huang3, Chunmeng Wei1,4
1Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning, Guangxi, China.
Abstract:
Cell-free DNA (cfDNA) has shown potential in distinguishing cancer patients from healthy individuals. This study investigates cfDNA fragmentomics-fragmentation patterns, end motifs (EDMs), and breakpoint motifs (BPMs)-to develop an early detection method for bladder urothelial carcinoma (BLCA), prostate adenocarcinoma (PRAD), and clear cell renal cell carcinoma (ccRCC). Using low-coverage whole genome sequencing (lcWGS) on plasma samples from 758 participants (including BLCA, PRAD, ccRCC, benign prostatic hyperplasia patients, and healthy controls), we analyzed cfDNA features. Machine learning models (logistic regression, support vector machine, random forest, XGBoost, Stacking) distinguished urological tumors from non-tumor cases with AUCs of 96% (BLCA), 99% (ccRCC), 92% (PRAD), and 89% (pan-cancer). Key discriminators included 6-bp EDMs and BPMs. A proposed two-tier screening strategy combining pan-cancer and cancer-specific features offers a cost-effective, non-invasive approach for early detection with strong clinical potential.
